Muhammad, Aziz

Surotomycin (A Novel Cyclic Lipopeptide) vs. Vancomycin for the Treatment of Clostridioides difficile Infection: A Systematic Review and Meta-analysis. [electronic resource] - Current clinical pharmacology 2019 - 166-174 p. digital

Publication Type: Comparative Study; Journal Article; Meta-Analysis; Systematic Review

2212-3938

10.2174/1574884714666190328162637 doi


Bias
Clostridium Infections--diagnosis
Humans
Lipopeptides--adverse effects
Peptides, Cyclic--adverse effects
Vancomycin--adverse effects